%PDF-1.7 % 10 0 obj << /Type /Page /Parent 1 0 R /LastModified (D:20210505031908-04'00') /Resources 2 0 R /MediaBox [0.000000 0.000000 595.276000 841.890000] /CropBox [0.000000 0.000000 595.276000 841.890000] /BleedBox [0.000000 0.000000 595.276000 841.890000] /TrimBox [0.000000 0.000000 595.276000 841.890000] /ArtBox [0.000000 0.000000 595.276000 841.890000] /Contents 11 0 R /Rotate 0 /Group << /Type /Group /S /Transparency /CS /DeviceRGB >> /PZ 1 >> endobj 11 0 obj <> stream x\rF}Wt\ep$w F vEIxL~&[L:h Vw6G\5*aX h05y.j:rq)AqL Eѯ*_fj˧0Ȃ#:ļ(kqRZ' z 6IƛM#FiUIlY6/58o@3"c'E%~|v\Yx=½ m̖i_ w1ڽ x6kXL9RQO7;1d]Nb:vw|(kS|3kTާ[N />9FrËШ"״q{%=5pIdb> V0ilXxaJ6Ŗw yEaR7Eʲ7 猪ݣ\^`|hҗ&=sY(1Y3Qb!%'"yǛ윽"󧧗N+!][Ud MUq zB ySRX16ypJUUk*0WiYA7gp]u˅"if 佤B &hI` S+L!wV''I[Y=D$-Ma 23 OzKF( 3|ar+qJ3GNS.CCt[Db*iH#TH=xd( ɞx~ b 20Qj{ ÏHnrh`I-K\݇XVLLC2sAX5daA)l)׼v?XAt$Pqi٦63Ϡ={~а}krmnF 俗Yzޱ;X{K|׿,fB2_uA"zB̚a&#K,^ĥJ*{ Jk?R*op&d[!0"Z~C}:|G]%Ww#]~xmS`Q E4E{>Om\~cpCsEuq%×x Q0!> /Annots [ 6 0 R 7 0 R 9 0 R ] /PZ 1 >> endobj 13 0 obj <> stream xWr6}Wc<#A753N[Ug:"! I0(Կ,֭vI0{vb(g 2dqvt~+?MatLvzA 77~?q}y<G,dQ iy1k•D{e;2 h Bѐ)0?gE 6P~OrL;_U +kF;:[YL1 K"aWVG7b _ЦrEfi7 b1!\"B-ėZ ^Jx1^e8DŽ cK >+zsr ASVqC$@3^za*˚Whg Liz1LDkh n-5IQK 9d>ge ~maop5\_Mෟ5U b*QC.S0jr<[*EcΔy4)}go/km?_JŰqWFЙ}Jp 3_^w)`iL_FjFzd OwFBYz`m[b:6:;A]hf;\/:&~ }[OPQFb(1, ¾(wsjSJ0tQ$A-/L endstream endobj 1 0 obj << /Type /Pages /Kids [ 10 0 R 12 0 R ] /Count 2 >> endobj 3 0 obj <> endobj 5 0 obj <> endobj 8 0 obj <> endobj 14 0 obj <> stream JFIFHHExifMM* z(1>?QQ Q HHPaint.NET v3.5.10z%u0`:oCC." }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?(f 1T$`9Sw(B@;~(]Cd꾫Es:aݻd2\(2F][&]ۢϲ|W͵L@A A 8 (CĝCglZE/ |Ezє{ xQʒ@[ྊ\/I4R0?6.7`ŴwPu|3/Z@Ogi}cFdFKoj?~8|p_A<ĺOkGPK $wRmkmF;YVx&rLj#p ׭axf|s$Ӿc:Qwm]N)Cψ[eYba98xB+oTÚwcRþ$U[ ?qΙ{&jv6Xo$=ԗ&7zgAxIִ.$3,mwc{+%g[!U@&Fϻm/#hci'7n[%It.&/ֶ+Zl~:wi~D>$}o+}@.[/+B6mnt8bi{zc.~F{eUe86g3 VT&> BK VؘXzSMesoM_&ϔIÍK?+hڿnt_ K]H '̽yrWA=O+|"!gɤItXe>Xs hwwG Eouqa /ş_~~'x} ]_^]/ 蚼:<cu/ h&omEۯicǪ\[,k}_uS}㏆W]G^tmf`Ks ]=va&h9n忔>75NWQτ0of,E (˰8hBC_ Jq'W UQKz,N>+`S%}b5ISJ]+(&QVN>eoy7xG4[]]3K{i$I>g-(mbynLIC,"*3f?-%`lfPx涽X"H'h"ֈ(TfeU:܉,a,R*I4xcxalOhGр|ia$cg,{gAHEu->]F,{-.,EX"I$XQD/3R.{{T&ҭ%4[OPnx"HhM :e}-Լ'=s:\iZ<+Lj5+1AɮLZx-☽G3 1I"kuχ+A}5'NxI8 gJk[oenm!x,=n=>}kjPx~M񧍼5k45a,RLiȖTFQMR&K;}r+XkY[y>2F=2~6>Gmi++<[WF76MH4>;;Kf۽ъM3ZE}c㿈*- -.|G5uI![ YR$$A>Eyׇ|7u;n>4׭JϷR[h!rVr\{~Ϛ >0jMg?_y_ Do/x;ÚƏi a𶕦f|Eqgk4V^RY]}F,/J%ՌAud%:x3Hg_4[+^ ҴKaXF'n.]Z(i$bef5GO:u]/a~.3N4xiG*a8ާ-U){G nJEڿ[m7wv5MYp|'gm # #%B?|鿲w­{+_|Q#VkxcZޛ{I]Wyak}..i˨iY9QwOA~hf{+ |Y;cڴ27G>|H,na8o; CEO,ZLP?SHK} e92W7/1aj¤aڄq4 қS7,5]%EƔc/uҒw\r/EnT y>!V+VK4X^Y{;+Ӫ=MqslEn?Zz'Ë}^2xĺGf70/M~*DU=坍G{wwvci%vZ$GY&J9dkՀ\6hs.F*ĩ"+S%s*{ qqDj3$ q^T24,Cn +=j񟍼q5k'\%ݎ{ͦuyq4X$y<ك2Ey%™|Icw]3#R[`{KցY [1*kLOdw ^OAkЏb<¿ <=6x0ׄ>(=*[ t]9-?IZ@}/>FۃQ@ endstream endobj 15 0 obj <> stream JFIFHHjPhotoshop 3.08BIMNUSTFBreast Cancer DruggNYSP102sAP720160813< 160758+0000 5xFILE - In a Saturday, Aug. 13, 2016 file photo, logo of Swiss pharmaceutical company Novartis is seen at the Novartis Korea office in Seoul, South Korea. U.S. regulators have approved a new drug as an initial treatment for postmenopausal women with a type of advanced breast cancer. The drug, called Kisqali, developed by Swiss drugmaker Novartis, is a pill that works to slow the spread of cancer by blocking two proteins that can stimulate growth and division of cancer cells. (AP Photo/Ahn Young-joon, File)zAYPAhn Young-joonZSeoulnAPeKORdKORtCopyright 2016 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistribu("SATURDAY, AUG. 13, 2016 FILE PHOTOIFILEExifII*@ (1 2;>?.^vi%A logo of Swiss pharmaceutical company Novartis is seen at the Novartis Korea office in Seoul, South Korea, Saturday, Aug. 13, 2016. Prosecutors indicted the former chief executive of the South Korean unit of Novartis and five other former and current managers over allegations they illegally paid doctors 2.6 billion won ($2.3 million) in return for prescribing the company's drugs. (AP Photo/Ahn Young-joon)CanonCanon EOS-1D XHHAdobe Photoshop CS5.1 Macintosh2017:03:13 17:12:09Ahn Young-joon9I@d!ddGddd+KrCopyright 2016 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistribu("'020230  &.6  >F1515150100ONV01 ^2k45 G 2016:08:13 16:07:582016:08:13 16:07:58w O4172018000065FEF70-200mm f/2.8L IS II USM0000c153cb R030100>F(N6 HH Adobe_CMAdobed            U" ?   3!1AQa"q2B#$Rb34rC%Scs5&DTdE£t6UeuF'Vfv7GWgw5!1AQaq"2B#R3$brCScs4%&5DTdEU6teuFVfv'7GWgw ?!DRũB)jg0AP1jJG@X 6RԔbHIHڈBhIHJJR5Q!THI4jBbS-Gl)  *^N>=4l-Vg>2n|I'I(yDWq{,>CKI{G%HT߄Ћ %)( ! $""!E4|%b5IHHJkm׸w#e%- Xۄ9*#``2KVRBy4m@l?*ÁRֵnA-"Za۽]UmHS)#U}~Q3*R%˛l$j@V] n? ?]Rr:WIY/s.$yqAB7JbYO_OZpe]O].ښ)7{UiԺ?}Cr]Sޟ`1ng%zk!_k4]r:Ndِ6nez̆dj.-~{Ow{CzRR_$xyc?%87.k@mϠu}Z_~cvgl7cƷ lΛZ4QH&(ff]&ۑ{ ֳ`o5^hxnU~S0?6`p5?bԷ:}*,-!4#r\2-Xe'f%^=2}b.mߢ[~09];H%k6K؃gkDuFwo؈>ǘ֯\ʟX$4>s`~oSlr*m򩿐-/t{?_~MO긦k6U:O{sccRLpJUN>˖9sw\R˙ijX?G?dpIBxA/芧Y{U¡el-{K]:" 6o]wȱ5{Άt7ӶkwAdnas~QU Z양H-b ^~wu]2?fpZܬ>Zӽ1,õ2ˠ۟UXtLPvO޳og6[Etǥ0CX@ )0}bwWcӲn~nbF+1 i{ZN]OPз!kZuLZElNٳw"OA6>}V:G7Uurz#~d YPm3cʥٖѯ^tZV/ֵN< ucs\];Lw}{9+Jko+]uZ+oU!%sák͡}[wz?g?h?bںlZۙTY) ,ev=! ?ڼ@k~vM9y]_mEOho>g}\I_㼄jz-ve6 fY~o=ObّX뵱aw]=UK_P<*gCVֿ֮`-{FF>SC/iAi'ioJD4f`Ypmsho;5KszMC \@ f ˩gLçc1is{:zN7%~8{Cғ+K)r(sgy3O JbBbd2 %0<*DjxbSJ1ILE$ܨʉ%#)Q))*+EOwQ+IO< I%>xP^ H}b$_h)SQ^8H}q$Lx^DJ}d+I/@ICC_PROFILE0ADBEmntrRGB XYZ  3;acspAPPLnone-ADBE cprt2desc0kwtptbkptrTRCgTRCbTRCrXYZgXYZbXYZtextCopyright 2000 Adobe Systems IncorporateddescAdobe RGB (1998)XYZ QXYZ curv3curv3curv3XYZ OXYZ 4,XYZ &1/ http://ns.adobe.com/xap/1.0/ FILE FILE - In a Saturday, Aug. 13, 2016 file photo, logo of Swiss pharmaceutical company Novartis is seen at the Novartis Korea office in Seoul, South Korea. U.S. regulators have approved a new drug as an initial treatment for postmenopausal women with a type of advanced breast cancer. The drug, called Kisqali, developed by Swiss drugmaker Novartis, is a pill that works to slow the spread of cancer by blocking two proteins that can stimulate growth and division of cancer cells. (AP Photo/Ahn Young-joon, File) Ahn Young-joon Breast Cancer Drug AP Item Id 3cc3cf81-8c51-41c4-9fa7-67d3fff35bcf AP Friendly Key 17072762951069 3cc3cf81-8c51-41c4-9fa7-67d3fff35bcf AP C  !"$"$CL !1AQaq"#2Brs$%345CRbc&6StTd7e'!12"AQa#3qB ?Z @4!&ܐD[mPlnt% A!@Y]G #Z4 8&MFTKЄvY! PK*h`x@@U FoR f݈b mQV^ B:RЖ&EP (BD%K!M ^%&H j؋TA@@CiklRT[ C@G$4[+,H)0%8 R K{ )@hPj*#" Y@ GU[lr w!YdYbWBY D-P^(!@"([@l[BY!ʄ1R:)jKSAH@,BYb%WAHMGbE URhE)),UMdȉ@@# Db$\Q!P"E!tmpCepD%HH6œ tHj7PB !! adIB4@,P AM]BB)j,sD)j@JA-t"wDH (A,HT)HiPUPm oR Dv TP=He-*r9PHdOB 1,7VT-ȡB1 " $( m`,ad:C'P#B)E)-#DTB%!BEPK *!DTQCZ"[TBj@ ʈ@8 B[Bsx[Q֊*A!ڣ! DE@*!(@D0 TF;) []#D)@X"A @DB jK  [ht B " EDRTDp O1eR P/R::+lp+{9EP7tB(cD ۔trM-uDtT˽.l.VUgQspvS;QnL^1&W'BqhvJSVE&=-mXӲ:']ŤzC򫨖jO ɕ*X/g'O={%COFa;bͱhk%B!jnR5@ZٹYEbxWaQ dR8 [ j!AEDX eaؚn G7Nbp6ɱPB W @y8F25A+ oPcl)*@ BB4Y `X8\" P .&Cp ?ǽF㇡sۗ9Hċ/l=87)T`q^^;h=vfn/W0SbN ʂBH+@sAPlpE+!@H&B!\,GXM*Y K"R;쀁Th%T(A\SC,4 rqP] DoE7x"L-g.lV͆],xskA$ @6e>=himD7SLxj hmuX^7K_|D?(]6mx(ب&bԠ*-g(ɄD0 [ "K:ZN'13V=mhO^e쥤$e_(ןN?vlʪa+<<<}]zיݎ>AaMSlx]-RhB)Hx.H*b [3\ l61tюt>)J&:Omf̘,o~)Hu>&5횗?WE੸WǴAf\{O@.'k$ow V5LdBT{ƷISWiEUFe7c9s7cXv 5 GMmuŏ_r[ kR&e\c*]m"h\8-L]TʹK,3Y1ry0VD3䑶 q6]vkӟi+\g1S$LfG )Ǝ}&Kj|K;)X*$6%hmqaǥi^K|aGZ19)0DLŮxǒI4֑GHG`%kUm+Fz)ETCßSvisHŧmˎ/vΜfHֶ3+{/:[|.j`~nOrۆ[ī]xT}!vrcUwòDŢXGT뉆ҾwrWja@'l$ΚG cbiELNb5Ynr.Y3e~mdiQXfLs,p[H+?ۮs`͵;l -yexY1ۓcָ!\Ͳnn7fM.䙎o$z@&g|nv,Whܲ?X/?4kr)H'@KcCqnjR-XӖqMrˀۣSyu{68F.kN#17ϦE''C>+ѩ{bZc9)_dXZ7 mVQ(k*Nn=eۃK͛TÝEED27C+vzӊxӻ.-Ӷ2\N}wO^i9D)oy]ٻ&7_h@u/>ݻ#tSY$=M>R&f|iB\s1VIb:Gdrޗ0pགtO2R."\fH?j{|hն](mL1Ľ$A-imn"VͫB{It6@&?}8F ;qOAPTn`K~}b :4nY9)ӴEBBޡy̻"5 F;-ۧn]!U{"en^3[z6rܻ7WйFnjlt계rQ'}u.|< mox22YYxZ$'8 ɀ/},]L75Դ` 84}೎zS9-[[oeY@ pEE$}N1͍a_VV^'X`pJ۝Ȃ}5eN S3cZ\w˚9ڪ.bn+ |l}ɞ;GRˑq~v&ǰ F˅T6hC.6Z$50 @Al?J(nT;QΖSq{MnV JCg gԉj\{e - ZbݎmԖܝ`v{^pb f͞ݱ}p FZv~ag}4pUgI)F}]zy=B2d4Ln3m y}%Qm S+۽5?n>ouۖ\&qCG2 a^fXIi*Oe/:mtêi˿$rc,0+vGM+8N3PXNm,uے N'ƣ<7bޝlǝ!%<կ->_oß ]{ > Ə3zY r_!55ywf>jDJa] 1ϠܸrvQak4.xuIY9|0G<eOţ!̕N!|HeÛPB럢|{jh]e] A,!] U iGj8 giWo~M5~Y!QcGWUsm-Lzӆ>W5a^~nՎ$`u,!C5ǽ{Oݧ4}%D?0zƟrӛ_^vOgm=V,*i> tӗ?oȳ$[|vq ,q0Mm|#*Z,N+2f!Qe mnח^^4 bǀZk zڻ9{]cUse!\l{ׁo'k_8E°`g}NX[)6M ⑷cZGbʿEW%;Oz" Z-r^5:q;G-X }Zn643u=S<^vJv0JcM H Z۽j)\ e `vtX_gɵ9i:,Y=9-C)c<b;Dg舛˒8ű[ NKχfkovz'nE3E0+Owާko~}-|gtr>cAS=?1O62Y(s^~wdN綾ET{vNܔY["p;>7.d]D^%zc{q-ZYy{f>h#fPSv~a~}]Yzr>-s^vHiV=Iz'[":P9%h(p>c!ZSlgU]qFlݡٽ/M1i๲:nފbܧ`Kg*ot~8\}.5jkMLڤap4YQʯ< @+֥xngPGگȑbWlj:6)r 7 =OtmGpAmZM4oS$|+R~S3,,u[\7!pdX~a`u,ҶX*1W%9VUzR{FUN1roݻ1r[膋4|}Ӑ nxk*GkUӟm6Gwe/$}9,b[&[!Ӈ#ҵ[t`8J=!7XR諎^Xکn(ѩk}A$rLa16~Rg7ĭY;wxWm_?S=+:nv/&[#yћ.sKoY#I$ooӟ|+J\ۼKLFґ楔|MTE㏠.d\j0$d<~uz[pbї- 4nm22R9TD}/W,\4\^ˍV^n^ݘzSg Usl t~[ʀT|4.Ǣl=ꖟqge=W67x>cǷEƷMYuP`0TjQ-$7V9jl3¸G+~+ʳlvEF];d":k/ZB:H%U缽'>If]n=Ҝ{G㌚ǖx,u斐ܱ[[dtmn @|3o̪w*^~N,K~-=a?d>]7 &lS/Ժxwt8겖5kZô#2{N}vHWmtr2=o ¼ܱ]t˵"jV8萭MY X5TpzRJ)M,^+/\:rvKr:8->Lvo[^IʎѶB?lﲺsz}y^nOge:_8PH66Ys#Ohuu^;|Ґh ŜJ+'}'L+tx+ٕ*YTB) !448#ǰ-Y?vR[+ox9iNcN^>OoHzغb\2ѝmGt_KeaWKa|TMصSlx5>%{uD6i;o/Z}*4S퇁[{4yw7' Ar7lV'>E5;V{F|:xMuFG)>,j,)n4hjE6!c) /n!y-fa2A }^MMV:E2yy^Gd9?I7v٧c4T 8:qo=LEm,nlp1z\fPn:K )ͤ[~wq-w+-w0%mJʳDMYϵNN8X$ܦ-;_ЬA' ͻΞn /:ΛFqHUE%#U0E)h;V[L[=+t{;zv=W\m4i6VV?{ݖ7W6>fE9;7{vc|.3;8~TWwW.~t̵7ʓ'e?D%0Ÿ8x.*5扭]U;|5#JX[yU6ZkpIWnqQBƗj\n ж!1#l> :G۩RM)KxݗNe s>/;/n=Yܱf ,&f9>!o y=TvEh;f 7NzDm&#ܞκtp RJm_ƨdTt٥w5Kh]:CDtds6|B]y>+fbtƝF: I/C˛(bÜw|Km?ΘE# ,7JylFp䈊 k#TB DE,28q,2t)}d3~XjOGN_dtxm,kۋɎ^Nغj?v5q,]C_*k8cocZ5\S^F&,qhtZkI٘jszvYh8QbsCa f7Iw-S)m;_n+}!fD<зÙh\=sz~_XoSoJ)D\.KV+|- L9τ|)+)" KnxGΕ X5im?Dž/:fQu9 ~X6+Nif8uRyzk'Tp7-q-͜H]uhmCYnH osnks2ŸNPj} 3̺hzFGio-Uu uTtNaoӞu/;z(%*/Ѽmn&]Tbͩ:,6-5 !.2;s Ydk}WW_4^Zj>7Y').a8:|I`%vG3ŕ[Ӎ茛P$ߐZǛMX#o]4}\u/RΒd>mmNgn3jxyeM6(a 褰P}W-Պ-b7;x^}Ӫ'ph%8K(17}x-0R6-dJn%>Ϭ ;(\7gr«-:|yL_oJ݃dQ_C'sO Z͛;ygK ֝Om4ytDn=u}"\?iː*uQx2FN8 ª꯫ag"zr~WR`Zր/m&YᾑTf(-m]l͋%D*JAME nf .ꥣpۆĩ\Hkr#NwQLpnC .k&h=Ejo]5y#,ؚGt6kAq $FV2t3̓sq"5y0՜k5TTKG9gU ;ɰhqơdǦmt4ŐgO{4,nXf'\6#sվS+\,Fu8VNh5r1Z2ϲ[ pQ-k1V %oxɞ|熻n#n= Fj0n0ɨ\ .XtK67Mip" #ԻGƓ2?+j][{]Ǭ\٧PێreZk cV1Vo(i!z{q5}(|OⱲױpUӎ9zW(S"pjl}V.X)Ӻm-Z;2U7 u'pNElCϜj$=>W9la b}|{+Өzˀ &!b˱M9%9s B)hecO6lbm A2[~7O#D ]CAC/S><;d" CyF^wDww5ӆVZ\Gbb] ճ/rO۲V|WTR{0Etcj~QY27SBKk``V+Ö-4KG/֙*+i3n}c@ƟsƸsFǝ pe ^˒#cJW̡$A3win.:aapYDܖb$GKt5j~]5zs>V;5uF,x.N -p`*7,:rR ]O,8Kҵjޔ2cq/cm$0{͓Sux])QTڴDdcf!UZiwZֺ>Lsi+1:q J T/kw^}4S%iJ- jpG\oK~aaq{]3ֱ=Ms.G1lʯZjf]Qx c{VC*j䜧06X]{.inX1C)qˣkR4|qi̛ۖ4TmK/Βe,q2kkrZ58k'{XLiEa--;bM+C--U5La!3$OmUnV1L4g+?D> l~Xxidve `l!vaJUS`P&  RSj.ٙotseS521LߎXmky4v-ݥ.J.cYmt]x6{McBݦ`%Ti,O2:z^imYL--ې{/1-\dX#loybZne|O@ik~3iw*+lwbF-Tbc5<#ll-4,y\R#cr8%3`5slV6܈tYDi%vIV>腮#}al^f `xh=qVr{10e>N_uc}G0ؘRjkFDk D at:xoʧoʙ~XE-7?fb%dxѭM  cκ  !:D6@)J e@@]] @ m)n25Au]*>(F@rKP!@ 'T@!nYDE3B Sc*18z)> stream xc``2ptqre``+) rwRR` ``\\yy 5F}Yd<^\PTQJjq2]^Rgd$e@좐 g ͗a_ ' v@t0l-bVep/,L(Q0200PpLOJU,.I-VK/*/J,IM ! A!ahiiI P<@X(v!ɥEePa>Œ9 KX Lz00OE2030ïPo endstream endobj 4 0 obj << /Type /XObject /Subtype /Form /FormType 1 /Filter /FlateDecode /BBox [0.000000 0.000000 595.276000 76.535433] /Matrix [1 0 0 1 0 0] /Resources << /ProcSet [/PDF /Text /ImageB /ImageC /ImageI] /Font << /F2 5 0 R /F1 3 0 R >> /XObject << /I0 14 0 R >> >> /Length 197 >> stream xKkBA WeI&ڊU/ nʥBf8A3!(X4`JQj*Aj͕197f hkL[=µrw]F D%x2WC0 9)Z ^Wh}29yyu?4g=bT1߻a endstream endobj 2 0 obj << /ProcSet [/PDF /Text /ImageB /ImageC /ImageI] /Font << /F1 3 0 R /F2 5 0 R /F3 8 0 R >> /XObject << /XT4 4 0 R /I0 14 0 R /I1 15 0 R >> >> endobj 6 0 obj <> /H /I>> endobj 7 0 obj <> /H /I>> endobj 9 0 obj <> /H /I>> endobj 17 0 obj << /Title (FDA OKs new Novartis drug for type of advanced breast cancer \(Update\)) /Subject (FDA OKs new Novartis drug for type of advanced breast cancer \(Update\)) /Creator (Science X Network) /Producer (TCPDF 6.3.5 \(http://www.tcpdf.org\)) /CreationDate (D:20210505031908-04'00') /ModDate (D:20210505031908-04'00') /Trapped /False >> endobj 18 0 obj << /Type /Metadata /Subtype /XML /Length 4795 >> stream application/pdf FDA OKs new Novartis drug for type of advanced breast cancer (Update) FDA OKs new Novartis drug for type of advanced breast cancer (Update) 2021-05-05T03:19:08-04:00 Science X Network 2021-05-05T03:19:08-04:00 2021-05-05T03:19:08-04:00 TCPDF 6.3.5 (http://www.tcpdf.org) uuid:912e1a3a-7eee-1cf0-5852-84e4cd959721 uuid:912e1a3a-7eee-1cf0-5852-84e4cd959721 http://ns.adobe.com/pdf/1.3/ pdf Adobe PDF Schema internal Adobe PDF Schema InstanceID URI http://ns.adobe.com/xap/1.0/mm/ xmpMM XMP Media Management Schema internal UUID based identifier for specific incarnation of a document InstanceID URI http://www.aiim.org/pdfa/ns/id/ pdfaid PDF/A ID Schema internal Part of PDF/A standard part Integer internal Amendment of PDF/A standard amd Text internal Conformance level of PDF/A standard conformance Text endstream endobj 19 0 obj << /Type /Catalog /Version /1.7 /Pages 1 0 R /Names << >> /ViewerPreferences << /Direction /L2R >> /PageLayout /SinglePage /PageMode /UseNone /OpenAction [10 0 R /FitH null] /Metadata 18 0 R >> endobj xref 0 20 0000000000 65535 f 0000004661 00000 n 0000037951 00000 n 0000004728 00000 n 0000037450 00000 n 0000004834 00000 n 0000038108 00000 n 0000038386 00000 n 0000004945 00000 n 0000038663 00000 n 0000000015 00000 n 0000000467 00000 n 0000003129 00000 n 0000003611 00000 n 0000005059 00000 n 0000010695 00000 n 0000037068 00000 n 0000038880 00000 n 0000039432 00000 n 0000044310 00000 n trailer << /Size 20 /Root 19 0 R /Info 17 0 R /ID [ <912e1a3a7eee1cf0585284e4cd959721> <912e1a3a7eee1cf0585284e4cd959721> ] >> startxref 44520 %%EOF